DianeJPragerMD

PubMed

• 19 citations
  A Phase 2 Randomized Trial of Paclitaxel and Carboplatin with or without Panitumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
  Jeffrey Crawford, Paul E. Swanson, Paul Schwarzenberger, Alan Sandler, Diane Prager, Kathy Zhang, Daniel J. Freeman, Carol W. Johnson, Kartik Krishnan, David H. Johnson> ;Journal of Thoracic Oncology. 2013 Dec 1
• 77 citations
  Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients Wi...
  David P. Steensma, Jeff A. Sloan, Shaker R. Dakhil, Robert J. Dalton, S. P. Kahanic, Diane Prager, Philip J. Stella, Kendrith M. Rowland, Paul J. Novotny, Charles L. L...> ;Journal of Clinical Oncology. 2011 Jan 1
• 45 citations
  Activation of the interleukin-10 gene in the human T lymphoma line HuT 78: identification and characterization of NF-κ B binding sites in the regulatory region of the ...
  Naoki Mori, Diane Prager> ;European Journal of Haematology. 2009 Apr 24
• 4 citations
  Transactivation of parathyroid hormone-related protein gene expression by human T-cell leukemia virus type I tax.
  Naoki Mori, Eri Ejima, Diane Prager> ;European Journal of Haematology. 2009 Apr 24
• 228 citations
  Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non-small-cell lung cancer
  John V. Heymach, Bruce E. Johnson, Diane Prager, Edit Csada, Jaromír Roubec, Miloš Pešek, Irena Spasova, Chandra P. Belani, Istvan Bodrogi, Shirish Gadgeel, Sarah J. K...> ;Journal of Clinical Oncology. 2007 Sep 20
• 57 citations
  Randomized Phase II Trial of Pemetrexed Combined With Either Cisplatin or Carboplatin in Untreated Extensive-Stage Small-Cell Lung Cancer
  Mark A. Socinski, Charles Weissman, Lowell L. Hart, J. Thaddeus Beck, Janak K. Choksi, John Hanson, Diane Prager, Matthew J. Monberg, Z. Ye, Coleman K. Obasaju> ;Journal of Clinical Oncology. 2006 Oct 20
• A phase II trial of ZD6474 plus docetaxel in patients with previously treated NSCLC: Follow-up results.
  Heymach JV, Johnson BE, Prager D, Csada E, Roubec J, Pesek M, Spasova I, Hou J, Kennedy S, Herbst RS> ;J. Clin. Oncol.. 2006-06-20
• 1187 citations
  TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer
  Roy S. Herbst, Diane Prager, Robert C. Hermann, Lou Fehrenbacher, Bruce E. Johnson, Alan B. Sandler, Mark G. Kris, Hai T. Tran, Pam Klein, Xin Li, D. Ramies, David H. ...> ;Journal of Clinical Oncology. 2005 Sep 1
• A randomized, placebo-controlled phase II trial of ZD6474 plus docetaxel, in patients with NSCLC.
  Heymach JV, Johnson BE, Rowbottom JA, Fidias P, Lu C, Prager D, Roubec J, Csada E, Dimery I, Herbst RS> ;J. Clin. Oncol.. 2005-06-01
• A randomized phase II trial of pemetrexed (P) plus cisplatin (cis) or carboplatin (carbo) in extensive stage small cell lung cancer (ES-SCLC).
  Socinski MA, Weissman CH, Hart LL, Beck JT, Choksi JK, Hanson JP, Prager D, Bloss LP, Ye Z, Obasaju CK> ;J. Clin. Oncol.. 2005-06-01
• Preliminary phase II safety evaluation of ZD6474, in combination with carboplatin and paclitaxel, as 1st-line treatment in patients with NSCLC.
  Johnson BE, Ma P, West H, Kerr R, Prager D, Sandler A, Herbst RS, Stewart DJ, Dimery IW, Heymach JV> ;J. Clin. Oncol.. 2005-06-01
• 97 citations
  Clinically meaningful improvement in symptoms and quality of life for patients with non-small-cell lung cancer receiving gefitinib in a randomized controlled trial.
  David Cella, Roy S. Herbst, Thomas J. Lynch, Diane Prager, Chandra P. Belani, Joan H. Schiller, Anne Heyes, Judith S. Ochs, Michael K. Wolf, Mark G. Kris, Ronald B. Na...> ;Journal of Clinical Oncology. 2005 May 1
• TRIBUTE - A phase III trial of erlotinib HCl (OSI-774) combined with carboplatin and paclitaxel (CP) chemotherapy in advanced non-small cell lung cancer (NSCLC).
  Herbst RS, Prager D, Hermann R, Miller V, Fehrenbacher L, Hoffman P, Johnson B, Sandler AB, Mass R, Johnson DH> ;J. Clin. Oncol.. 2004-07-15
• Long survival of never smoking non-small cell lung cancer (NSCLC) patients (pts) treated with erlotinib HCl (OSI-774) and chemotherapy: Sub-group analysis of TRIBUTE.
  Miller VA, Herbst R, Prager D, Fehrenbacher L, Hermann R, Hoffman P, Johnson B, Sandler AB, Kris MG, Ramies D> ;J. Clin. Oncol.. 2004-07-15
• Randomized phase II trial of pemetrexed with either cisplatin or carboplatin in extensive stage small cell lung cancer.
  Socinski MA, Weissman C, Hart LL, Choksi JK, Holladay C, Prager D, Obasaju CK> ;J. Clin. Oncol.. 2004-07-15
• 2084 citations
  Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients with Non-Small Cell Lung Cancer: A Randomized Trial
  Mark G. Kris, Ronald B. Natale, Roy S. Herbst, Thomas J. Lynch, Diane Prager, Chandra P. Belani, Joan H. Schiller, Karen Kelly, Harris Spiridonidis, Alan B. Sandler, K...> ;JAMA. 2003 Oct 22
• 14 citations
  Phase II trial of irinotecan in combination with amifostine in patients with advanced colorectal carcinoma
  Maria L. Delioukina, Diane Prager, Mandy Parson, J. Randolph Hecht, Peter Rosen, Lee S. Rosen> ;Cancer. 2002 Apr 15
• 61 citations
  SAFETY AND EFFICACY OF EXISULIND FOR TREATMENT OF RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY
  Erik T. Goluboff, Diane Prager, Daniel B. Rukstalis, Bruce J. Giantonio, Martin Madorsky, Israel Barken, I. Bernard Weinstein, Alan W. Partin, Carl A. Olsson> ;The Journal of Urology. 2001 Sep 1
• 14 citations
  A phase II trial of irinotecan in hormone-refractory prostate cancer
  David M. Reese, Simon Tchekmedyian, Yvonne Chapman, Diane Prager, Peter Rosen> ;Investigational New Drugs. 1998 Dec 1
• 22 citations
  Interleukin-10 Gene Expression and Adult T-Cell Leukemia
  Naoki Mori, Diane Prager> ;Leukemia & Lymphoma. 1998 Apr 1
• 20 citations
  Repression of transcription from the human T-cell leukemia virus type I long terminal repeat and cellular gene promoters by wild-type p53.
  Naoki Mori, Fatah Kashanchi, Diane Prager> ;Blood. 1997 Dec 15
• 8 citations
  Transactivation of the Interleukin-1 Alpha Promoter by Human T-cell Leukemia Virus
  Naoki Mori, Diane Prager> ;Leukemia & Lymphoma. 1997 Aug 1
• 84 citations
  Multiple myeloma cells are protected against dexamethasone-induced apoptosis by insulin-like growth factors
  Feng-hao Xu, Agnes Gardner, Yiping Tu, Patrick Michl, Diane Prager, Alan Lichtenstein> ;British Journal of Haematology. 1997 May 1
• 79 citations
  Interleukin-10 gene expression in adult T-cell leukemia.
  Naoki Mori, Parkash S. Gill, Tarsem Mougdil, Shuichi Murakami, Sumiya Eto, Diane Prager> ;Blood. 1996 Aug 1
• 145 citations
  Transactivation of the interleukin-1alpha promoter by human T-cell leukemia virus type I and type II Tax proteins
  Naoki Mori, Diane Prager> ;Blood. 1996 Apr 15
• Join now to see all